The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Regulation of the Human hsp70 Promoter by p53
Abstract
The tumor suppressor p53 is a nuclear phosphoprotein with characteristics of a transcription factor. It displays sequence-specific DNA binding, contains a potent transactivation domain, and has been implicated as both a transcriptional activator and a repressor. Transcription of the human hsp70 gene is stimulated by adenovirus E1a protein. This E1a transactivation of the hsp70 promoter is mediated by CCAAT binding factor (CBF). It is demonstrated here that p53 both represses transcription from the human hsp70 promoter and also interacts with CBF. Thus, the repression of the hsp70 promoter by p53 may be mediated by direct protein-protein interaction with CBF. These results suggest that protein-protein interaction between p53 and specific transcription factors may be an additional mechanism by which p53 regulates gene expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 1993, p53 was first reported to bind to coactivators, including the TATA-box binding protein,73, 74 the CCAAT-box binding factor (NF-Y)75 and specificity protein 1 (Sp1) that binds to GC-boxes,76 and to interfere with their transactivator function.”
From Census and evaluation of p53 target genes (2017) · cites this paper as [75]
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Recombinant Genomes Which Express Chloramphenicol Acetyltransferase in Mammalian Cells
Gorman, C., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,674
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- Haley, K. P., Proceedings of the National Academy of Sciences of the United States of America 81: 5734 (1984).
- LUM, SYL, MOL CELL BIOL 12: 2599 (1992).
- Mercer, W. E., Proceedings of the National Academy of Sciences of the United States of America 79: 6309 (1982).
Cited by
Sorted by citations
Items 101–200 of 292
D’Souza, S., Xin, H., Walter, S., & Choubey, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007155200 · Cited by 72
The Structure, Function, and Regulation of Papillomaviral Genes in Infection and Cervical Cancer
Turek, L. P. (1994) · Advances in virus research · doi:10.1016/s0065-3527(08)60332-2 · Cited by 71
p53-Dependent Signal Transduction Induced by Stress.
Wang, X., & Ohnishi, T. (1997) · Journal of Radiation Research · doi:10.1269/jrr.38.179 · Cited by 70
Goldsmith, M. E., Gudas, J. M., Schneider, E., & Cowan, K. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1894 · Cited by 67
Taira, T., Sawai, M., Ikeda, M., Tamai, K., Iguchi‐Ariga, S. M. M., & Ariga, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24270 · Cited by 67
Wawrzynów, B., Żylicz, M., & Żylicz, M. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.12.004 · Cited by 65
Ikeda, J., Nakajima, T., Osborne, O. C., Mies, G., & Nowak, T. S. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90097-3 · Cited by 65
Response of heat shock element within the human HSP70 promoter to mutated p53 genes.
Tsutsumi‐Ishii, Y., Tadokoro, K., Hanaoka, F., & Tsuchida, N. (1995) · PubMed · Cited by 64
Feng, X., Bonni, S., & Riabowol, K. T. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01538-06 · Cited by 63
Molecular chaperones in mammary cancer growth and breast tumor therapy
Calderwood, S. K., & Gong, J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23461 · Cited by 62
Heat‐shock protein expression on the membrane of T cells undergoing apoptosis
Poccia, F., Piselli, P., Vendetti, S., Bach, S., Amendola, A., Placido, R., & Colizzi, V. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-656.x · Cited by 61
Ohnishi, K., Takahashi, A., Yokota, S., & Ohnishi, T. (2004) · International Journal of Radiation Biology · doi:10.1080/09553000412331283470 · Cited by 60
DNA damage, oncogenesis and the p53 tumour-suppressor gene
Lee, J. M., Abrahamson, J., & Bernstein, A. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90267-4 · Cited by 59
Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
Liu, P. K., Kraus, E., Wu, T., Strong, L. C., & Tainsky, M. A. (1996) · PubMed · Cited by 59
Interactions Between Papillomavirus Proteins and Tumor Suppressor Gene Products
Vousden, K. H. (1994) · Advances in cancer research · doi:10.1016/s0065-230x(08)60833-7 · Cited by 59
One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
Böhlig, L., & Rother, K. (2011) · BioMed Research International · doi:10.1155/2011/464916 · Cited by 58
Takahashi, A. (2001) · International Journal of Radiation Biology · doi:10.1080/09553000010009495 · Cited by 57
To repress or not to repress: This is the guardian's question
Rinn, J. L., & Huarte, M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.04.002 · Cited by 60
Li, B., Greenberg, N. M., Stephens, L. C., Meyn, R. E., Medina, D., & Rosen, J. M. (1994) · PubMed · Cited by 55
Polyglutamine gene function and dysfunction in the ageing brain
Hands, S. L., Sinadinos, C., & Wyttenbach, A. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.05.008 · Cited by 55
Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression
Nozaki, M., Tada, M., Kobayashi, H., Zhang, C.-L., Sawamura, Y., Abe, H., Ishii, N., & Meir, E. G. V. (1999) · Neuro-Oncology · doi:10.1215/s1522851798000179 · Cited by 53
Wu, K., Jiang, S. W., & Couch, F. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211297200 · Cited by 50
HSP-CBF Is an NF-Y-dependent Coactivator of the Heat Shock Promoters CCAAT Boxes
Imbriano, C., Bolognese, F., Gurtner, A., Piaggio, G., & Mantovani, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101553200 · Cited by 52
HIV-1-Infected Astrocytes and the Microglial Proteome
Wang, T., Gong, N., Liu, J., Kadiu, I., Kraft-Terry, S. D., Schlautman, J. D., Ciborowski, P. S., Volsky, D. J., & Gendelman, H. E. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9110-x · Cited by 51
Kelavkar, U. P., & Badr, K. F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4378 · Cited by 49
Yang, X., Pater, A., & Tang, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202843 · Cited by 50
p53: DNA damage, DNA repair, and apoptosis
Götz, C., & Montenarh, M. (1995) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0048265 · Cited by 50
Suppression of Ceramide-mediated Apoptosis by HSP70
Ahn, J., Ko, Y., Park, W., Kang, Y.-S., Chung, H. Y., & Seo, J. (1999) · Molecules and Cells · doi:10.1016/s1016-8478(23)13530-8 · Cited by 48
Matsui, T., Katsuno, Y., Inoue, T., Fujita, F., Joh, T., Niida, H., Murakami, H., Itoh, M., & Nakanishi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403232200 · Cited by 47
van der Watt, P. J., & Leaner, V. D. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.05.017 · Cited by 47
p53, proto-oncogene and rheumatoid arthritis
Sun, Y., & Cheung, H. S. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.31550 · Cited by 45
Pathogenesis of Warthin’s tumors
Kuzenko, Y. V., Romanuk, A. M., Diachenko, O., & Olena, H. (2016) · Interventional Medicine and Applied Science · doi:10.1556/1646.8.2016.2.2 · Cited by 45
Chen, Y., Lin‐Shiau, S., & Lin, J. (1999) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1999.tb01952.x · Cited by 45
Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter.
Osifchin, N. E., Jiang, D., Ohtani‐Fujita, N., Fujita, T., Carroza, M., Kim, S. J., Sakai, T., & Robbins, P. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37383-0 · Cited by 44
Subler, M. A., Martin, D. W., & Deb, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.103-110.1994 · Cited by 45
HPV16 E5 deregulates the autophagic process in human keratinocytes
Belleudi, F., Nanni, M., Raffa, S., & Torrisi, M. R. (2015) · Oncotarget · doi:10.18632/oncotarget.3326 · Cited by 44
The Role of Stress Proteins in Prostate Cancer
So, A., Hadaschik, B. A., Sowery, R. D., & Gleave, M. E. (2007) · Current Genomics · doi:10.2174/138920207781386951 · Cited by 45
Edskes, H. K., Ohtake, Y., & Wickner, R. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.28912 · Cited by 44
Mathematical modeling of heat shock protein synthesis in response to temperature change
Szymańska, Z., & Żylicz, M. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.03.021 · Cited by 44
Little, E., Tocco, G., Baudry, M., Lee, A. S., & Schreiber, S. S. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00267-9 · Cited by 44
Park, C., Joo, I. S., Song, S., Kim, D. S., Bae, D., & Lee, J.-H. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5429 · Cited by 42
Loging, W., & Reisman, D. (1999) · Oncogene · doi:10.1038/sj.onc.1203135 · Cited by 41
Pre-irradiation at a Low Dose-rate Blunted p53 Response
Takahashi, A. (2002) · Journal of Radiation Research · doi:10.1269/jrr.43.1 · Cited by 41
Proteins with transcription regulatory properties encoded by human adenoviruses
Akusjärvi, G. (1993) · Trends in Microbiology · doi:10.1016/0966-842x(93)90085-6 · Cited by 40
Role of p53 in Regulating Radiation Responses
Okazaki, R. (2022) · Life · doi:10.3390/life12071099 · Cited by 40
The Bradykinin Type 2 Receptor Is a Target for p53-mediated Transcriptional Activation
Saifudeen, Z. R., Du, H., Dipp, S., & El-Dahr, S. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909810199 · Cited by 38
p53 in the anticancer mechanism of vitamin E
SCHWARTZ, J. L., Shklar, G., & Trickler, D. P. (1993) · European Journal of Cancer Part B Oral Oncology · doi:10.1016/0964-1955(93)90055-j · Cited by 39
Marwaha, V., Chen, Y., Helms, E., Arad, S., Inoue, H., Bord, E., Kishore, R., Sarkissian, R. D., Gilchrest, B. A., & Goukassian, D. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503245200 · Cited by 37
Transcriptional Regulation of the Steroid Receptor Genes
Kumar, M. V., & Tindall, D. J. (1997) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(08)61035-1 · Cited by 38
Heat shock proteins in animal neoplasms and human tumours—a comparison
Romanucci, M., Bastow, T., & Salda, L. D. (2008) · Cell Stress and Chaperones · doi:10.1007/s12192-008-0030-8 · Cited by 37
Soussi, T. (1995) · Advances in genome biology · doi:10.1016/s1067-5701(06)80005-7 · Cited by 37
Bondesson, M., Mannervik, M., Akusjärvi, G., & Svensson, C. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.3053 · Cited by 37
Gualberto, A., Hixon, M. L., Finco, T. S., Perkins, N. D., Nabel, G. J., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3450 · Cited by 37
SV40 Large T Antigen Transactivates the Human Promoter by Inducing a CCAAT Box Binding Factor
Chen, H., Campisi, J., & Padmanabhan, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.13959 · Cited by 36
Selter, H., & Montenarh, M. (1994) · International Journal of Biochemistry · doi:10.1016/0020-711x(94)90139-2 · Cited by 36
Down-regulation of fibronectin gene expression by the p53 tumor suppressor protein.
Iotsova, V., & Stéhelin, D. (1996) · PubMed · Cited by 35
Pise-Masison, C. A., Dittmer, J., Clemens, K. E., & Brady, J. N. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1236 · Cited by 34
Zwacka, R. M., & Dunlop, M. G. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70010-1 · Cited by 34
Molecular Mechanisms Involved in Adaptive Responses to Radiation, UV light, and Heat
Takahashi, A., & Ohnishi, T. (2009) · Journal of Radiation Research · doi:10.1269/jrr.09048s · Cited by 34
E2Fs and the Retinoblastoma Protein Family
Sardet, C., Cam, L. L., Fabbrizio, E., & Vidal, M. (1997) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8934-6_1 · Cited by 33
Tissue-specific p53 expression in the nervous system
Tendler, Y., Weisinger, G., Coleman, R., Diamond, E., Lischinsky, S., Kerner, H., Rotter, V., & Zinder, O. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00202-8 · Cited by 32
Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation
el-Mahdani, N., Vaillant, J. C., Guiguet, M., Prevot, S., Bertrand, V., Bernard, C., Parc, R., Bereziat, G., & Hermelin, B. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.92 · Cited by 32
Modulation of the expression of the rabbit galectin-3 gene by p53 and c-Ha-ras proteins and PMA
Gaudin, J., Arar, C., Monsigny, M. L. P., & Legrand, A. (1997) · Glycobiology · doi:10.1093/glycob/7.8.1089 · Cited by 31
Inactive p53 mutants may enhance the transcriptional activity of wild-type p53.
Zhang, W., Shay, J. W., & Deisseroth, A. (1993) · PubMed · Cited by 30
Structure, function and evolution of DnaJ: conservation and adaptation of chaperone function
Cheetham, M. E., & Caplan, A. J. (1998) · Cell Stress and Chaperones · doi:10.1379/1466-1268(1998)003 · Cited by 604
p53 Acts as a Co-Repressor to Regulate Keratin 14 Expression during Epidermal Cell Differentiation
Cai, B., Hsu, P.-C., Hsin, I., Chao, C., Lu, M., Lin, H.-C., Chiou, S., Tao, P., & Chen, J.-Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041742 · Cited by 31
p53-HSP70 complexes in oral dysplasia and cancer: Potential prognostic implications
Kaur, J., Srivastava, A., & Ralhan, R. (1996) · European Journal of Cancer Part B Oral Oncology · doi:10.1016/0964-1955(95)00054-2 · Cited by 29
Luo, X., He, Q., Huang, Y., & Sheikh, M. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1132 · Cited by 29
Wild-Type p53 Regulates Its Own Transcription in a Cell-Type Specific Manner
Hudson, J. M., Frade, R., & Bar‐Eli, M. (1995) · DNA and Cell Biology · doi:10.1089/dna.1995.14.759 · Cited by 29
P53 Activates Fanconi Anemia Group C Gene Expression
Liebetrau, W., Budde, A., Savoia, A., Grummt, F., & Hoehn, H. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.277 · Cited by 27
p53-dependent downregulation of metastasis-associated laminin receptor
Modugno, M., Tagliabue, E., Ardini, E., Berno, V., Galmozzi, E., Bortoli, M. D., Castronovo, V., & Ménard, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205957 · Cited by 28
Faour, W. H., He, Q., Mancini, A. D., Jovanović, D., Battista, J. A. D., & Battista, J. A. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601293200 · Cited by 28
Targeting gene expression to tumor cells with loss of wild-type p53 function
Zhu, J., Gao, B., Zhao, J., & Balmain, A. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700091 · Cited by 26
HSF1-Mediated Regulation of Tumor Cell Apoptosis: A Novel Target for Cancer Therapeutics
Kumar, S., Tomar, M. S., & Acharya, A. (2013) · Future Oncology · doi:10.2217/fon.13.106 · Cited by 26
Repression of Human Reduced Folate Carrier Gene Expression by Wild Type p53
Ding, B. C., Whetstine, J. R., Witt, T. L., Schuetz, J. D., & Matherly, L. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005248200 · Cited by 26
Lee, H., Kim, H. T., & Yun, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19786 · Cited by 26
Calabrò, V., Mansueto, G., Santoro, R., Gentilella, A., Pollice, A., Ghioni, P., Guerrini, L., & Mantia, G. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8529-8540.2004 · Cited by 26
Marks, J. R., Davidoff, A. M., & Iglehart, J. D. (1995) · Humana Press eBooks · doi:10.1007/978-1-4757-2381-6_4 · Cited by 25
Chang, N.-T., Yang, W., Huang, H.-C., Yeh, K., & Wu, C.-W. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-006-9126-2 · Cited by 25
Stathmin in cell proliferation and cancer progression
Sherbet, G. V., & Cajone, F. (2005) · PubMed · doi:10.25405/ncl.34617762 · Cited by 25
Transactivation of the Human cdc 2 Promoter by Adenovirus E1A
Kao, C., Tanimoto, A., Arima, N., Sasaguri, Y., & Padmanabhan, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23043 · Cited by 25
The characterisation of p53 binding phage isolated from phage peptide display libraries
Daniels, D. A., & Lane, D. P. (1994) · Journal of Molecular Biology · doi:10.1016/0022-2836(94)90038-8 · Cited by 25
Sharma, A., Meena, A. S., & Bhat, M. K. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01516.x · Cited by 24
Roemer, K., & Friedmann, T. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21718.x · Cited by 24
Modulation of Interleukin-6-induced Plasma Protein Secretion in Hepatoma Cells by p53 Species
Wang, L., Rayanade, R. J., García, D., Patel, K., Pan, H., & Sehgal, P. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.23159 · Cited by 24
Regulation of HSF1-responsive gene expression by N-terminal truncated form of p73α
Tanaka, Y., Kameoka, M., Itaya, A., Ota, K., & Yoshihara, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.124 · Cited by 23
Psychiatric morbidity in terminally III cancer patients: A prospective study
Minagawa, H., Uchitomi, Y., Yamawaki, S., & Ishitani, K. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960901)78:5 · Cited by 243
The Phosphotyrosyl Phosphatase Activator Gene Is a Novel p53 Target Gene
Janssens, V., HOOF, C. V., BAERE, I. D., Merlevede, W. J., & Goris, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909370199 · Cited by 22
A novel G1-specific enhancer identified in the human heat shock protein 70 gene
Taira, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.10.1975 · Cited by 21
Ranki, A., Lassus, J., & Niemi, K. ‐. (1995) · Acta Dermato Venereologica · doi:10.2340/0001555575180186 · Cited by 21
Heat Shock Proteins in Glioblastomas
Yang, I., Fang, S., & Parsa, A. T. (2009) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2009.09.002 · Cited by 20
Zhang, D., Cao, D., Russell, R. L., & Pizzorno, G. (2001) · PubMed · Cited by 20
Ling, C. A. I., & Zhu, J. (2003) · Cell Research · doi:10.1038/sj.cr.7290154 · Cited by 20
Nakade, K., Zheng, H., Ganguli, G., Buchwalter, G., Gross, C., & Wasylyk, B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1132-1142.2004 · Cited by 20
Mori, N., Kashanchi, F., & Prager, D. (1997) · Blood · doi:10.1182/blood.v90.12.4924 · Cited by 20
Joshi, A. A., Wu, Z., Reed, R. F., & Suttle, D. P. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.359 · Cited by 18
p53-dependent regulation of heat shock protein 72
Quenneville, L., Trotter, M. J., Maeda, T., & Tron, V. A. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04721.x · Cited by 18
The Deprivation Syndrome is the Driving Force of Phylogeny, Ontogeny and Oncogeny
Heininger, K. (2001) · Reviews in the Neurosciences · doi:10.1515/revneuro.2001.12.3.217 · Cited by 18
Markopoulos, A. K., Deligianni, E., & Antoniades, D. (2009) · Chemotherapy · doi:10.1159/000218099 · Cited by 17
Prolonged c-jun expression in irradiated ataxia telangiectasia fibroblasts
Hallahan, D. E., Dunphy, E., Kuchibhotla, J., Kraft, A., Unlap, T., & Weichselbaum, R. R. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00327-6 · Cited by 16
Metadata
- Authors
- Agoff, S. N., Hou, J., Linzer, D. I., & Wu, B.
- Affiliations
- Northwestern University (US)
- Venue
- Science
- Published
- 1993-01
- Volume
- 259
- Issue
- 5091
- Pages
- 84-87
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2061154169
- Cited by
- 292
- References
- 54
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 6 · 2022: 2 · 2021: 1 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 6
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- p53, HSP70 gene, promoter regulation, transcriptional repression, CCAAT-binding factor, protein-protein interaction, adenovirus E1A, transcriptional activator, tumor suppressor, gene expression regulation
- MeSH terms
- Base Sequence, Cloning, Molecular, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Escherichia coli, Gene Expression Regulation, Heat-Shock Proteins, Humans, Promoter Regions, Genetic, Recombinant Fusion Proteins, Transcription Factors, Transcription, Genetic, Chloramphenicol O-Acetyltransferase, Tumor Suppressor Protein p53, TATA Box, Adenovirus E1A Proteins, CCAAT-Enhancer-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review